Hadasit Bio (HDST) - Total Liabilities

Latest as of June 2023: ILA3.73 Million ILA ≈ $9.99K USD

Based on the latest financial reports, Hadasit Bio (HDST) has total liabilities worth ILA3.73 Million ILA (≈ $9.99K USD) as of June 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Hadasit Bio (HDST) net asset momentum to track the company's year-over-year net asset growth rate.

Hadasit Bio - Total Liabilities Trend (2008–2022)

This chart illustrates how Hadasit Bio's total liabilities have evolved over time, based on quarterly financial data.

Hadasit Bio Competitors by Total Liabilities

The table below lists competitors of Hadasit Bio ranked by their total liabilities.

Company	Country	Total Liabilities
PREMIA FINANCE O.N. F:81U	Germany	€1.78 Million
DevvStream Corp. Common Stock NASDAQ:DEVS	USA	$26.61 Million
Canada One Mining Corp V:CONE	Canada	CA$1.95 Million
Oldfields Holdings Ltd AU:OLH	Australia	AU$26.16 Million
TELES Informationstechnologien AG XETRA:TLIK	Germany	€4.29 Million
Capella Minerals Ltd V:CMIL	Canada	CA$1.84 Million
Frontier Developments Plc LSE:FDEV	UK	GBX42.42 Million
CPT GLOBAL LTD F:714	Germany	€8.09 Million

Liability Composition Analysis (2008–2022)

This chart breaks down Hadasit Bio's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Hadasit Bio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hadasit Bio's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hadasit Bio (2008–2022)

The table below shows the annual total liabilities of Hadasit Bio from 2008 to 2022.

Year	Total Liabilities	Change
2022-12-31	ILA3.88 Million ≈ $10.39K	+436.84%
2021-12-31	ILA722.00K ≈ $1.94K	-83.10%
2020-12-31	ILA4.27 Million ≈ $11.45K	+9.23%
2019-12-31	ILA3.91 Million ≈ $10.49K	+278.61%
2018-12-31	ILA1.03 Million ≈ $2.77K	-86.78%
2017-12-31	ILA7.81 Million ≈ $20.94K	-0.32%
2016-12-31	ILA7.84 Million ≈ $21.01K	-5.69%
2015-12-31	ILA8.31 Million ≈ $22.28K	-19.38%
2014-12-31	ILA10.31 Million ≈ $27.63K	+4.41%
2013-12-31	ILA9.87 Million ≈ $26.46K	+34.76%
2012-12-31	ILA7.33 Million ≈ $19.64K	-8.25%
2011-12-31	ILA7.98 Million ≈ $21.40K	-0.04%
2010-12-31	ILA7.99 Million ≈ $21.41K	+14.84%
2009-12-31	ILA6.96 Million ≈ $18.65K	+100.61%
2008-12-31	ILA3.47 Million ≈ $9.29K	--

About Hadasit Bio

TA:HDST Israel Biotechnology & Medical Research

Market Cap

$1.81 Million

ILA674.18 Million ILA

Market Cap Rank

#30086 Global

#443 in Israel

Share Price

ILA60.80

Change (1 day)

-1.78%

52-Week Range

ILA30.00 - ILA83.00

All Time High

ILA2847.77